FDA takes second action under international collaboration, approves new treatment option for patients with chronic lymphocytic leukaemia

21 November 2019 - Today, as part of Project Orbis, a collaboration with the Australian Therapeutic Goods Administration and Health Canada, ...

Read more →

Health Canada approves new drug to treat metastatic breast cancer through international and domestic joint reviews

9 April 2019 - Canadians want improved access to the most recent and innovative treatment options for themselves and their ...

Read more →

Health Canada offers HTA aligned reviews for drugs and biologics

25 June 2018 - Sponsors of biologics and new drug submissions now have the option of requesting aligned regulatory reviews ...

Read more →

Incorporating the patient experience into regulatory decision making in the USA, Europe, and Canada

26 April 2018 - The clinical development of cancer therapeutics is a global undertaking, and incorporation of the patient experience into ...

Read more →